Loading...
Core Scientific Inc (CORZ) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance has been weak, with significant declines in revenue, net income, and EPS. While analysts have raised price targets and hedge funds are buying, the technical indicators and options data suggest limited short-term upside. Additionally, there are no strong proprietary trading signals to support an immediate buy decision. Holding or exploring other opportunities may be more prudent.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 47.629, showing no clear trend. Moving averages are converging, suggesting a lack of directional strength. Key support is at 15.382, and resistance is at 18.706. The stock has a 60% chance of declining in the next day, week, and month.

Analysts have raised price targets significantly, with a consensus that the company has strong growth potential in the HPC infrastructure space. Hedge fund buying has increased by 104.24% over the last quarter, indicating institutional confidence.
The company is undergoing a pivot from Bitcoin mining to HPC leasing, which introduces execution risk. Recent financial performance has been poor, with revenue, net income, and EPS all showing significant declines. Insider trading trends are neutral, and there is no recent congress trading data to indicate confidence from influential figures.
In Q3 2025, revenue dropped by -14.95% YoY to $81.1 million. Net income declined by -57.05% YoY to -$147.5 million. EPS fell by -60.68% YoY to -0.46. Gross margin dropped significantly to 4.81, down -3106.25% YoY, reflecting severe profitability challenges.
Analysts are optimistic about the company's transition to HPC infrastructure, with recent upgrades and raised price targets (e.g., $25, $23, and $30). They see potential for growth in securing new HPC colocation contracts and view the rejection of the CoreWeave merger as a positive strategic move.